Global Plasmid DNA CDMO Service Market Research Report 2024

Publication ID:

PB509246778

Publication Date:

September 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Plasmid DNA CDMO (Contract Development and Manufacturing Organization) services involve providing specialized support for the development, production, and commercialization of plasmid DNA used in biopharmaceutical applications. These services cater to the growing demand for plasmid DNA, which plays a crucial role in gene therapy, cell therapy, vaccines, and other biotechnological advancements.
The global Plasmid DNA CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Plasmid DNA CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Plasmid DNA CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Plasmid DNA CDMO Service in Preclinical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Plasmid DNA CDMO Service include Creative Biogene, AGC Biologics, Biovian, GenScript ProBio, Charles River Laboratories, PackGene, Catalent Biologics, Patheon, Mycenax Biotech Inc, VGXI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Plasmid DNA CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid DNA CDMO Service.
The Plasmid DNA CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasmid DNA CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid DNA CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biogene
AGC Biologics
Biovian
GenScript ProBio
Charles River Laboratories
PackGene
Catalent Biologics
Patheon
Mycenax Biotech Inc
VGXI
Esco Aster
Eurogentec
53Biologics
SK pharmteco
Cytovance Biologics
Aldevron
Bionova Scientific
Segment by Type
Research Grade
Commercial Grade
GMP Grade
Others
Segment by Application
Preclinical
Clinical
Commercial
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid DNA CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Research Grade
1.2.3 Commercial Grade
1.2.4 GMP Grade
1.2.5 Others
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA CDMO Service Market Perspective (2019-2030)
2.2 Global Plasmid DNA CDMO Service Growth Trends by Region
2.2.1 Global Plasmid DNA CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasmid DNA CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 Plasmid DNA CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 Plasmid DNA CDMO Service Market Dynamics
2.3.1 Plasmid DNA CDMO Service Industry Trends
2.3.2 Plasmid DNA CDMO Service Market Drivers
2.3.3 Plasmid DNA CDMO Service Market Challenges
2.3.4 Plasmid DNA CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA CDMO Service Players by Revenue
3.1.1 Global Top Plasmid DNA CDMO Service Players by Revenue (2019-2024)
3.1.2 Global Plasmid DNA CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global Plasmid DNA CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plasmid DNA CDMO Service Revenue
3.4 Global Plasmid DNA CDMO Service Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Service Revenue in 2023
3.5 Global Key Players of Plasmid DNA CDMO Service Head office and Area Served
3.6 Global Key Players of Plasmid DNA CDMO Service, Product and Application
3.7 Global Key Players of Plasmid DNA CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA CDMO Service Breakdown Data by Type
4.1 Global Plasmid DNA CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global Plasmid DNA CDMO Service Forecasted Market Size by Type (2025-2030)
5 Plasmid DNA CDMO Service Breakdown Data by Application
5.1 Global Plasmid DNA CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global Plasmid DNA CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plasmid DNA CDMO Service Market Size (2019-2030)
6.2 North America Plasmid DNA CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plasmid DNA CDMO Service Market Size by Country (2019-2024)
6.4 North America Plasmid DNA CDMO Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid DNA CDMO Service Market Size (2019-2030)
7.2 Europe Plasmid DNA CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plasmid DNA CDMO Service Market Size by Country (2019-2024)
7.4 Europe Plasmid DNA CDMO Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA CDMO Service Market Size (2019-2030)
8.2 Asia-Pacific Plasmid DNA CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plasmid DNA CDMO Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Plasmid DNA CDMO Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid DNA CDMO Service Market Size (2019-2030)
9.2 Latin America Plasmid DNA CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plasmid DNA CDMO Service Market Size by Country (2019-2024)
9.4 Latin America Plasmid DNA CDMO Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA CDMO Service Market Size (2019-2030)
10.2 Middle East & Africa Plasmid DNA CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biogene
11.1.1 Creative Biogene Company Details
11.1.2 Creative Biogene Business Overview
11.1.3 Creative Biogene Plasmid DNA CDMO Service Introduction
11.1.4 Creative Biogene Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.1.5 Creative Biogene Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics Plasmid DNA CDMO Service Introduction
11.2.4 AGC Biologics Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.2.5 AGC Biologics Recent Development
11.3 Biovian
11.3.1 Biovian Company Details
11.3.2 Biovian Business Overview
11.3.3 Biovian Plasmid DNA CDMO Service Introduction
11.3.4 Biovian Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.3.5 Biovian Recent Development
11.4 GenScript ProBio
11.4.1 GenScript ProBio Company Details
11.4.2 GenScript ProBio Business Overview
11.4.3 GenScript ProBio Plasmid DNA CDMO Service Introduction
11.4.4 GenScript ProBio Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.4.5 GenScript ProBio Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Plasmid DNA CDMO Service Introduction
11.5.4 Charles River Laboratories Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.5.5 Charles River Laboratories Recent Development
11.6 PackGene
11.6.1 PackGene Company Details
11.6.2 PackGene Business Overview
11.6.3 PackGene Plasmid DNA CDMO Service Introduction
11.6.4 PackGene Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.6.5 PackGene Recent Development
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Details
11.7.2 Catalent Biologics Business Overview
11.7.3 Catalent Biologics Plasmid DNA CDMO Service Introduction
11.7.4 Catalent Biologics Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.7.5 Catalent Biologics Recent Development
11.8 Patheon
11.8.1 Patheon Company Details
11.8.2 Patheon Business Overview
11.8.3 Patheon Plasmid DNA CDMO Service Introduction
11.8.4 Patheon Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.8.5 Patheon Recent Development
11.9 Mycenax Biotech Inc
11.9.1 Mycenax Biotech Inc Company Details
11.9.2 Mycenax Biotech Inc Business Overview
11.9.3 Mycenax Biotech Inc Plasmid DNA CDMO Service Introduction
11.9.4 Mycenax Biotech Inc Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.9.5 Mycenax Biotech Inc Recent Development
11.10 VGXI
11.10.1 VGXI Company Details
11.10.2 VGXI Business Overview
11.10.3 VGXI Plasmid DNA CDMO Service Introduction
11.10.4 VGXI Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.10.5 VGXI Recent Development
11.11 Esco Aster
11.11.1 Esco Aster Company Details
11.11.2 Esco Aster Business Overview
11.11.3 Esco Aster Plasmid DNA CDMO Service Introduction
11.11.4 Esco Aster Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.11.5 Esco Aster Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Details
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Plasmid DNA CDMO Service Introduction
11.12.4 Eurogentec Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.12.5 Eurogentec Recent Development
11.13 53Biologics
11.13.1 53Biologics Company Details
11.13.2 53Biologics Business Overview
11.13.3 53Biologics Plasmid DNA CDMO Service Introduction
11.13.4 53Biologics Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.13.5 53Biologics Recent Development
11.14 SK pharmteco
11.14.1 SK pharmteco Company Details
11.14.2 SK pharmteco Business Overview
11.14.3 SK pharmteco Plasmid DNA CDMO Service Introduction
11.14.4 SK pharmteco Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.14.5 SK pharmteco Recent Development
11.15 Cytovance Biologics
11.15.1 Cytovance Biologics Company Details
11.15.2 Cytovance Biologics Business Overview
11.15.3 Cytovance Biologics Plasmid DNA CDMO Service Introduction
11.15.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.15.5 Cytovance Biologics Recent Development
11.16 Aldevron
11.16.1 Aldevron Company Details
11.16.2 Aldevron Business Overview
11.16.3 Aldevron Plasmid DNA CDMO Service Introduction
11.16.4 Aldevron Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.16.5 Aldevron Recent Development
11.17 Bionova Scientific
11.17.1 Bionova Scientific Company Details
11.17.2 Bionova Scientific Business Overview
11.17.3 Bionova Scientific Plasmid DNA CDMO Service Introduction
11.17.4 Bionova Scientific Revenue in Plasmid DNA CDMO Service Business (2019-2024)
11.17.5 Bionova Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Creative Biogene
AGC Biologics
Biovian
GenScript ProBio
Charles River Laboratories
PackGene
Catalent Biologics
Patheon
Mycenax Biotech Inc
VGXI
Esco Aster
Eurogentec
53Biologics
SK pharmteco
Cytovance Biologics
Aldevron
Bionova Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂